Abstract:
The headquarters of Sandoz in Basle have been carrying out a primary research program on a new drug for the treatment of rheumatic diseases, and are intending to carry out a market research program in the USA, Germany and the UK to explore the potential market for this new drug. In the UK, Sandoz themselves have carried out group discussions which have produced information on basic medical attitudes to this disease area and its drug therapy.
Research Reports
Qualitative research on Fenopron
Catalogue: CRAM/Peter Cooper Archive Collection
Author: CRAM/Peter Cooper Archive
 
September 1, 1975
Research Reports
Distalgesic advertising research
Catalogue: CRAM/Peter Cooper Archive Collection
Author: CRAM/Peter Cooper Archive
 
May 1, 1976
Research Reports
Key factors in the changing state of medical marketing
Catalogue: CRAM/Peter Cooper Archive Collection
Author: CRAM/Peter Cooper Archive
 
September 1, 1976
